Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

nitpicker

(7,153 posts)
Fri Oct 16, 2020, 12:46 PM Oct 2020

Remdesivir has very little effect on Covid-19 mortality, WHO finds

This discussion thread was locked as off-topic by applegrove (a host of the Latest Breaking News forum).

Source: The Guardian

Remdesivir has very little effect on Covid-19 mortality, WHO finds
Results of major trial described as sobering, with drug found not to improve survival rates

Fri 16 Oct 2020 13.00 BSTFirst published on Fri 16 Oct 2020 12.58 BST

Remdesivir, one of the big treatment hopes for Covid-19, has very little effect on preventing deaths, according to a large and comprehensive trial run by the World Health Organization.

The drug, made by the US biotech firm Gilead, has been talked up as a potential cure and was taken by Donald Trump. A trial in the US had previously showed it reduced the length of stay in hospital. But the gold-standard Solidarity WHO trial, which was based on a far larger sample – 3,000 people on the drug, compared with as many who were not – showed remdesivir had little effect on deaths over 28 days.
(snip)

The WHO’s guideline committee will look at the data from its trial and others and decide what recommendations to make about the drug.

Three other drugs were trialled in the Solidarity study, which has recruited more than 12,000 patients across 30 countries, and none had very much effect on mortality. They were hydroxychloroquine, which had already been found to have no benefit by the University of Oxford’s Recovery trial, lopinavir, an antiretroviral used in HIV treatment, and interferon, given as an injection under the skin.
(snip)

Read more: https://www.theguardian.com/world/2020/oct/16/remdesivir-has-very-little-effect-on-covid-19-mortality-who-finds-trial-drug-coronavirus

8 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Remdesivir has very little effect on Covid-19 mortality, WHO finds (Original Post) nitpicker Oct 2020 OP
To my knowledge, Dexamethasone is the only drug yet proven to be effective. Laelth Oct 2020 #1
And... FarPoint Oct 2020 #2
Yes. That's because it's really old. Laelth Oct 2020 #3
I see... FarPoint Oct 2020 #4
It has the same side effects as other corticosteroids. Phoenix61 Oct 2020 #6
Interferon A given by nebulizer has shown early promise Warpy Oct 2020 #5
This message was self-deleted by its author sarcasmo Oct 2020 #7
LOCKING applegrove Oct 2020 #8

Laelth

(32,017 posts)
1. To my knowledge, Dexamethasone is the only drug yet proven to be effective.
Fri Oct 16, 2020, 01:12 PM
Oct 2020

And it’s quite dangerous—used only on the most severe cases like the President.

-Laelth

FarPoint

(12,444 posts)
2. And...
Fri Oct 16, 2020, 01:14 PM
Oct 2020

It's cheap

Laelth

(32,017 posts)
3. Yes. That's because it's really old.
Fri Oct 16, 2020, 01:19 PM
Oct 2020

Trump, naturally, argued that the Regeneron he took is what made him feel better. He owns stock in the company that makes Regeneron, but Dexamethasone is undoubtedly what did it. He just can’t make money on that drug.

-Laelth

FarPoint

(12,444 posts)
4. I see...
Fri Oct 16, 2020, 01:23 PM
Oct 2020

We are on the same train of thought.

Phoenix61

(17,019 posts)
6. It has the same side effects as other corticosteroids.
Fri Oct 16, 2020, 01:54 PM
Oct 2020

When used with covid patients it's been shown to improve the outcomes for those on oxygen or mechanical breathing assistance. It has no impact on other covid patients. This actually makes sense since the thought is lung inflammation is due to the body's immune response rather than a direct effect of the virus.

Warpy

(111,352 posts)
5. Interferon A given by nebulizer has shown early promise
Fri Oct 16, 2020, 01:51 PM
Oct 2020

It was simply ineffective given by other routes.

I read early last summer that remdesivir was most effective in mild cases that people would have recovered from with no treatment. That bit of news came out while Dumdum and Jarjar were cornering the world supply of it.

There is no silver bullet for this thing. Some people will get better with supportive treatment and some will die and right now, there's nothing much we can do about it. While the monocolonal antibodies might improve things, the immense cost and difficulty in manufacturing them will preclude wide distribution.

Our best hope now, as it has been from the beginning, is a vaccine. If reinfection after a year or two proves common, we'll likely see a yearly combination jab for Covid and flu.

Response to nitpicker (Original post)

applegrove

(118,793 posts)
8. LOCKING
Fri Oct 16, 2020, 04:37 PM
Oct 2020

Alert: duplicate post

Below is the previous LBN OP on the same topic:

https://www.democraticunderground.com/10142605767

Statement of Purpose LBN

Post the latest news from reputable mainstream news websites and blogs. Important news of national interest only. No analysis or opinion pieces. No duplicates. News stories must have been published within the last 12 hours. Use the published title of the story as the title of the discussion thread.

Latest Discussions»Latest Breaking News»Remdesivir has very littl...